Director, Medical Affairs Oncology, Strategic Evidence & Collaborations (SEC)

At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives and to ensure access to these therapies across the globe. We continue to fight against the world’s biggest health challenges, and our mission requires collaboration, determination and a relentless drive to make a difference.   Every member of Gilead’s team plays a critical role in the discovery and development of life-changing scientific innovations. Our employees are our greatest asset as we work to achieve our bold ambitions, and we’re looking for the next wave of passionate and ambitious people ready to make a direct impact.   We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Gilead and help create possible, together.

We have an exciting opportunity within US Medical Affairs for   a   Director , Medical Affairs Oncology, Strategic Evidence & Collaborations (SEC) . This role will be remote but will require headquarters   travel   for specific meetings quarterly.     Reporting to the Senior Director and Head of Strategic Evidence & Collaborations, US Medical Affairs (USMA), the core efforts of this role is to be responsible for co-developing the US Medical Affairs strategy for US Medical Affairs congress plans in collaboration with the COE (Congress Center of Excellence) and the USMA Strategy and Field Based Medical Teams.     The key functions of this role will be to represent and consider the healthcare environment of the US with internal and external stakeholders involved in cancer therapies across approved and pipeline molecules and indications, including the Global Medical Affairs team, US Medical Access and Quality team, Scientific Communications/Publications, Medical Affairs Outcomes Research, Commercial Strategy, Marketing, Value and Market Access,  Clinical Research/Development, US Public Affairs, US Government Affairs ,Patient Engagement, Business Conduct (Legal), and the field-based US Medical Science Liaisons.

Must be able to travel more than 50% of the time, including a mix of domestic and international travel.

As an integral part of the USMA Oncology team, and in close collaboration with Oncology medical directors, Field Medical., Global Medical   Affairs , Medical   Affairs Research,   Medical   Patient Access and Quality, and cross-functional partners, this role will establish and execute an overarching strategy for evidence generation across various tumor types in the US,   including collaboration   with cooperative groups, NCI/CTEP, and other key organizations. This role will also provide frequent internal and external input into the development of both the US and Global Medical Affairs Strategic Plans for   our ADC portfolio , particularly the Integrated Strategic Plan (ISP) . Additionally, the role will   be a key contributor to the US   and   Global medical   Plan of Action (POA)      Specific responsibilities for this role will include, but are not limited to:     Demonstrate deep subject matter   expertise   in   our full   ADC portfolio, the Gilead   clinical trials and their clinical use, as well as competitive products   Colla borate   a s   a tho ugh t   partner   and   sign ificant   co ntri b u tor   to the   suc cess ful   w or k   lead   by   the Comm unity   Cancer C ollec tive   Team   (CC C)    Contribute to the development of the Global Integrated Strategic Plan (ISP) and Local Plan of   Action   (POAs) by providing US   and Global